|
AU4504000A
(en)
*
|
1993-04-27 |
2000-09-07 |
Sepracor, Inc. |
Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
|
|
SE9301489D0
(sv)
*
|
1993-04-30 |
1993-04-30 |
Ab Astra |
Veterinary composition
|
|
US6875872B1
(en)
|
1993-05-28 |
2005-04-05 |
Astrazeneca |
Compounds
|
|
DE4324014C2
(de)
*
|
1993-07-17 |
1995-06-08 |
Byk Gulden Lomberg Chem Fab |
Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung
|
|
TW280770B
(ru)
|
1993-10-15 |
1996-07-11 |
Takeda Pharm Industry Co Ltd |
|
|
SE9402431D0
(sv)
*
|
1994-07-08 |
1994-07-08 |
Astra Ab |
New tablet formulation
|
|
EE03305B1
(et)
*
|
1994-07-08 |
2000-12-15 |
Astra Aktiebolag |
Paljuosaline tableteeritud annusvorm I
|
|
ES2094694B1
(es)
*
|
1995-02-01 |
1997-12-16 |
Esteve Quimica Sa |
Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
|
|
SE9500478D0
(sv)
*
|
1995-02-09 |
1995-02-09 |
Astra Ab |
New pharmaceutical formulation and process
|
|
US5945124A
(en)
*
|
1995-07-05 |
1999-08-31 |
Byk Gulden Chemische Fabrik Gmbh |
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
|
|
DE69631834T2
(de)
*
|
1995-09-21 |
2005-02-10 |
Pharma Pass Ii Llc, Irvine |
Neues ein säureempfindliches benzimidazol enthaltendes mittel und verfahren zu dessen herstellung
|
|
SI9700186B
(sl)
|
1997-07-14 |
2006-10-31 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
|
|
ES2137862B1
(es)
*
|
1997-07-31 |
2000-09-16 |
Intexim S A |
Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
|
|
ES2362418T3
(es)
*
|
1997-12-08 |
2011-07-05 |
Nycomed Gmbh |
Nueva forma de supositorio que comprende un compuesto activo ácido-lábil.
|
|
DK173431B1
(da)
|
1998-03-20 |
2000-10-23 |
Gea Farmaceutisk Fabrik As |
Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
|
|
JP4127740B2
(ja)
*
|
1998-04-20 |
2008-07-30 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
安定化したベンズイミダゾール系化合物含有組成物
|
|
EP1004305B1
(en)
*
|
1998-04-20 |
2011-09-28 |
Eisai R&D Management Co., Ltd. |
Stabilized compositions containing benzimidazole-type compounds
|
|
WO1999059544A2
(en)
|
1998-05-18 |
1999-11-25 |
Takeda Chemical Industries, Ltd. |
Orally disintegrable tablets
|
|
ZA9810765B
(en)
*
|
1998-05-28 |
1999-08-06 |
Ranbaxy Lab Ltd |
Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
|
|
CA2507743C
(en)
*
|
1998-08-12 |
2008-03-18 |
Altana Pharma Ag |
Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles
|
|
DE19843413C1
(de)
*
|
1998-08-18 |
2000-03-30 |
Byk Gulden Lomberg Chem Fab |
Neue Salzform von Pantoprazol
|
|
KR100833633B1
(ko)
|
1999-06-07 |
2008-05-30 |
니코메드 게엠베하 |
산에 불안정한 활성 화합물을 포함하는 신규 제제 및 투여형태
|
|
ES2168043B1
(es)
|
1999-09-13 |
2003-04-01 |
Esteve Labor Dr |
Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
|
|
CA2387746C
(en)
|
1999-10-20 |
2010-06-29 |
Koji Ukai |
Methods for stabilizing benzimidazole-based compounds
|
|
DE19959419A1
(de)
|
1999-12-09 |
2001-06-21 |
Ratiopharm Gmbh |
Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
|
|
DK1108425T3
(da)
*
|
1999-12-16 |
2005-09-26 |
Medinfar Produtos Farmaceutico |
Nye, stabile flerenhedspræparater, der indeholder substituerede benzimidazoler
|
|
AU2277101A
(en)
*
|
1999-12-20 |
2001-07-03 |
Schering Corporation |
Stable extended release oral dosage composition
|
|
AU2276801A
(en)
|
1999-12-20 |
2001-07-03 |
Schering Corporation |
Extended release oral dosage composition
|
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
|
WO2002045692A1
(en)
*
|
2000-12-07 |
2002-06-13 |
Altana Pharma Ag |
Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
|
|
MXPA04002980A
(es)
|
2001-09-28 |
2005-06-20 |
Johnson & Johnson |
Formas de dosificacion que tienen un nucleo interior y coraza exterior con diferentes formas.
|
|
US20050163846A1
(en)
*
|
2001-11-21 |
2005-07-28 |
Eisai Co., Ltd. |
Preparation composition containing acid-unstable physiologically active compound, and process for producing same
|
|
US20050220870A1
(en)
*
|
2003-02-20 |
2005-10-06 |
Bonnie Hepburn |
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
|
US8449911B2
(en)
*
|
2003-03-12 |
2013-05-28 |
Takeda Pharmaceutical Company Limited |
Drug composition having active ingredient adhered at high concentration to spherical core
|
|
CL2004000983A1
(es)
*
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
|
AU2003245033A1
(en)
*
|
2003-05-08 |
2004-11-26 |
Podili Khadgapathi |
An improved and stable pharmaceutical composition containing substituted benzimidazoles and a process for its preparation
|
|
PE20050150A1
(es)
*
|
2003-05-08 |
2005-03-22 |
Altana Pharma Ag |
Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
|
|
US20050147663A1
(en)
*
|
2003-07-17 |
2005-07-07 |
Mohan Mailatur S. |
Method of treatment for improved bioavailability
|
|
RU2375048C2
(ru)
*
|
2003-07-17 |
2009-12-10 |
Д-Р Редди'С Лабораторис Инк. |
Фармацевтическая композиция с набухающим покрытием
|
|
NZ544608A
(en)
*
|
2003-07-17 |
2008-07-31 |
Reddys Lab Ltd Dr |
Pharmaceutical compositions having a swellable coating comprising prolamin
|
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
AU2004271747A1
(en)
*
|
2003-09-18 |
2005-03-24 |
Altana Pharma Ag |
Use of known active ingredients as radical scavengers
|
|
TWI372066B
(en)
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
|
WO2005034924A1
(en)
*
|
2003-10-14 |
2005-04-21 |
Natco Pharma Limited |
Enteric coated pellets comprising esomeprazole, hard gelatin capsule containing them, and method of preparation
|
|
US20050175689A1
(en)
*
|
2003-10-27 |
2005-08-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Coated fine particles containing drug for intrabuccally fast disintegrating tablet
|
|
US20070065513A1
(en)
*
|
2003-10-31 |
2007-03-22 |
Avi Avramoff |
Stable lansoprazole formulation
|
|
WO2005046634A2
(de)
*
|
2003-11-14 |
2005-05-26 |
Siegfried Generics International Ag |
Magensaftresistente verabreichungsform
|
|
HU227317B1
(en)
*
|
2003-11-25 |
2011-03-28 |
Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag |
Enteric coated tablet containing pantoprazole
|
|
US20050244490A1
(en)
*
|
2003-12-09 |
2005-11-03 |
Michael Otto |
Dosing methods for beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy
|
|
WO2005076987A2
(en)
*
|
2004-02-10 |
2005-08-25 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
|
|
RU2359670C2
(ru)
*
|
2004-03-25 |
2009-06-27 |
Астеллас Фарма Инк. |
Композиция солифенацина или его соли для использования в твердом препарате
|
|
NZ549838A
(en)
*
|
2004-03-26 |
2010-04-30 |
Eisai R&D Man Co Ltd |
Coated controlled-release preparation containing a gastric acid secretion inhibitor
|
|
ES2376466T3
(es)
*
|
2004-05-07 |
2012-03-14 |
Nycomed Gmbh |
Forma de dosificación farmacéutica que comprende peletes, as�? como su procedimiento de fabricación.
|
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
US20050281876A1
(en)
*
|
2004-06-18 |
2005-12-22 |
Shun-Por Li |
Solid dosage form for acid-labile active ingredient
|
|
US20060024362A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
|
DE102004042139B4
(de)
*
|
2004-08-31 |
2009-06-10 |
Aristocon Verwaltungs- Gmbh |
Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
|
|
WO2006066932A1
(en)
*
|
2004-12-24 |
2006-06-29 |
Lek Pharmaceuticals D.D. |
Stable pharmaceutical composition comprising an active substance in the form of solid solution
|
|
US20080103171A1
(en)
*
|
2004-12-27 |
2008-05-01 |
Astellas Pharma Inc. |
Stable Particular Pharmaceutical Composition of Solifenacin or Salt Thereof
|
|
WO2006085335A2
(en)
*
|
2005-01-03 |
2006-08-17 |
Lupin Limited |
Pharmaceutical composition of acid labile substances
|
|
US8673352B2
(en)
|
2005-04-15 |
2014-03-18 |
Mcneil-Ppc, Inc. |
Modified release dosage form
|
|
EP1895990A2
(en)
*
|
2005-05-13 |
2008-03-12 |
Combino Pharm, S.L. |
Formulations containing pantoprazole free acid and its salts
|
|
US7815939B2
(en)
*
|
2005-07-20 |
2010-10-19 |
Astellas Pharma Inc. |
Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
|
|
EP1747776A1
(en)
|
2005-07-29 |
2007-01-31 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Pharmaceutical composition comprising granular pantoprazole
|
|
EP1930030A1
(en)
*
|
2005-09-29 |
2008-06-11 |
Eisai R&D Management Co., Ltd. |
Pulse preparation having improved disintegration properties in vivo
|
|
CA2624179A1
(en)
*
|
2005-10-06 |
2007-04-12 |
Auspex Pharmaceuticals, Inc. |
Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
|
|
US8486450B2
(en)
|
2005-12-28 |
2013-07-16 |
Takeda Pharmaceutical Company Limited |
Method of producing solid preparation disintegrating in the oral cavity
|
|
EP1973532A1
(en)
*
|
2006-01-16 |
2008-10-01 |
Jubilant Organosys Limited |
Stable pharmaceutical formulation of an acid labile compound and process for preparing the same
|
|
US20100297226A1
(en)
*
|
2006-06-01 |
2010-11-25 |
Dexcel Pharma Technologies Ltd. |
Multiple unit pharmaceutical formulation
|
|
GB2459393B
(en)
|
2006-10-05 |
2010-09-08 |
Santarus Inc |
Novel capsule formulation for the proton pump inhibitor omeprazole
|
|
US20100105738A1
(en)
*
|
2006-10-06 |
2010-04-29 |
Mitsuru Mizuno |
Extended release formulations of a proton pump inhibitor
|
|
WO2008057802A2
(en)
|
2006-10-27 |
2008-05-15 |
The Curators Of The University Of Missouri |
Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
|
|
CA2673665C
(en)
|
2006-12-22 |
2017-03-21 |
Ironwood Pharmaceuticals, Inc. |
Method and compositions for treating esophageal disorders
|
|
EP2471516A3
(en)
|
2007-09-14 |
2012-12-26 |
Wockhardt Limited |
Rhein or diacerein compositions
|
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
|
DE102010052847A1
(de)
*
|
2010-11-29 |
2012-05-31 |
Temmler Werke Gmbh |
Verfahren zur Herstellung einer PPI-haltigen pharmazeutischen Zubereitung
|
|
EA201591338A1
(ru)
|
2013-01-15 |
2016-01-29 |
Айронвуд Фармасьютикалз, Инк. |
Гастроретентивная лекарственная форма секвестранта желчных кислот с замедленным высвобождением для перорального применения
|
|
WO2016126625A1
(en)
|
2015-02-03 |
2016-08-11 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating upper gastrointestinal disorders in ppi refractory gerd
|
|
US20170042806A1
(en)
|
2015-04-29 |
2017-02-16 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
|
CN108065443B
(zh)
*
|
2017-12-30 |
2020-02-28 |
厦门金达威维生素有限公司 |
斥水型双包被微胶囊及其制备方法
|
|
CN114569579B
(zh)
|
2020-12-02 |
2023-10-31 |
丽珠医药集团股份有限公司 |
肠溶微丸、其制备方法和包含它的制剂
|
|
WO2024075017A1
(en)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition of aortic valve calcification
|